Showing results (61-70 of 81) with videos related to
Sort By:
Pageof 9
Cancer Genetics and Cytogenetics|June 9, 2007
Incidence of submicroscopic deletions vary according to disease entities and chromosomal translocations in hematologic malignancies: investigation by fluorescence in situ hybridizationHee Won Moon, Yoon Hwan Chang, Tae Young Kim, et al.Cancer Genetics and Cytogenetics|February 19, 2002
Predominance of trisomy 1q in myelodysplastic syndromes in Korea: is there an ethnic difference? A 3-year multi-center studyDong Soon Lee, Sun Hee Kim, Eul Ju Seo, et al.Cancer Genetics and Cytogenetics|January 29, 2003
RARA fluorescence in situ hybridization overcomes the drawback of PML/RARA fluorescence in situ hybridization in follow-up of acute promyelocytic leukemiaDong Soon Lee, Yun Song Lee, Young Ree Kim, et al.Leukemia Research|December 13, 2006
MTHFR 677CC/1298CC genotypes are highly associated with chronic myelogenous leukemia: a case-control study in KoreaHee Won Moon, Tae Young Kim, Bo Ra Oh, et al.International Journal of Hematology|July 9, 2004
Extramedullary relapse confirmed by fluorescence in situ hybridization study of an ear mass in acute promyelocytic leukemiaKeun-Wook Lee, Jongyoun Yi, Tak Yun, et al.Cancer Genetics and Cytogenetics|April 18, 2006
Deletion of any part of the BCR or ABL gene on the derivative chromosome 9 is a poor prognostic marker in chronic myelogenous leukemiaYoung Kyung Lee, Young Ree Kim, Hyun Chung Min, et al.Acta Haematologica|February 21, 2008
Protective role of CYP1A1*2A in the development of multiple myelomaSeong-Ho Kang, Tae Young Kim, Ho Young Kim, et al.Genes, Chromosomes & Cancer|May 22, 2003
A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progressionDong Soon Lee, Yun-Song Lee, Yeon-Sook Yun, et al.The Korean Journal of Parasitology|December 12, 2012
Serologic survey of toxoplasmosis in Seoul and Jeju-do, and a brief review of its seroprevalence in KoreaHyemi Lim, Sang-Eun Lee, Bong-Kwang Jung, et al.American Journal of Clinical Pathology|January 15, 2009
Erythrocyte sedimentation rate measurements by TEST 1 better reflect inflammation than do those by the Westergren method in patients with malignancy, autoimmune disease, or infectionChoong-Hwan Cha, Chan-Jeoung Park, Young Joo Cha, et al.Pageof 9